13 / 31
Prosigna identifies intermediate/high
risk patients more accurately than Oncotype
Dowset M et al,
Dowsett et al. SABCS 2011, JCO 2013
|
|
13 / 31
13 / 31
Prosigna identifies intermediate/high
risk patients more accurately than Oncotype
Dowset M et al,
Dowsett et al. SABCS 2011, JCO 2013